[1]
“Formulation and development of industry feasible proniosomal transdermal drug delivery system of granisetron hydrochloride”,
AJP
, vol. 9, no. 2, pp. 113–119, Apr. 2015, doi:
10.22377/ajp.v9i2.440
.